Table 1.
Clinical characteristics of patients with HCC and CRLM
| Factor | HCC2n = 11 | CRLM3n = 23 |
| Localization of primary tumor | ||
| Liver | 11 | - |
| Colon | - | 14 |
| Rectum | - | 9 |
| Gender | ||
| Male | 5 | 17 |
| Female | 6 | 6 |
| Age, yr4 | 62.6 (29-82) | 65.0 (39-76) |
| Hepatitis (A, B or C) | ||
| Positive | 4 | 1 |
| Negative | 7 | 22 |
| Liver chirrhosis | ||
| Positive | 5 | 6 |
| Negative | 6 | 17 |
| Fibrosis | ||
| Positive | 1 | 3 |
| Negative | 10 | 20 |
| Largest tumor diameter (cm)4 | 4.3 (1.2-6.8) | 10.3 (1.3-19) |
| TNM1 stage of primary tumor | ||
| I | 2 | 2 |
| II | 4 | 2 |
| III | 5 | 15 |
| IV | 0 | 3 |
| Grading | ||
| I | 0 | 2 |
| II | 7 | 16 |
| III | 4 | 5 |
| IV | 0 | 0 |
| Lymphatic permeation | ||
| Positive | 1 | 16 |
| Negative | 10 | 7 |
| Vascular invasion | ||
| Positive | 4 | 1 |
| Negative | 7 | 22 |
| Chemotherapy before operation | 0 | 13 |
| Radiotherapy before operation | 0 | 3 |
1
Tumor-node-metastasis;
2
Hepatocellular carcinoma;
3
Colorectal liver metastases;
4
Median with range in parentheses.